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DEFINING THE ROLE OF THE KINASE MST4 IN THE CONTEXT OF THE 
HIPPO TUMOR SUPPRESSOR PATHWAY 
IAN PAOLO MORELOS MAURICIO 
ABSTRACT 
The Hippo tumor suppressor pathway is a highly conserved signaling 
cascade initially identified in Drosophila which acts to regulate organ size and 
cellular proliferation. The Hippo pathway integrates extracellular and intracellular 
cues such as cytoskeletal tension, growth factor signaling, and nutrient availability 
to ultimately activate the LATS kinases.  Activated LATS kinases then inhibit the 
downstream oncoproteins YAP and TAZ via a phosphorylation-dependent 
mechanism, in which 14-3-3 dependent cytoplasmic sequestration promotes 
YAP/TAZ degradation via the ubiquitin-proteasome pathway.   
Upstream regulators of LATS activation remain poorly characterized. 
MST1/2, which are mammalian orthologs of the Drosophila Hpo kinase, appear to 
be largely dispensable for Hippo pathway activation, suggesting evolutionary 
redundancy arising as a result of divergence and diversification of MSTs in human 
cells. We identified MST4, a close cousin of MST1/2, as a potential novel regulator 
of Hippo signaling in non-transformed, non-polarized human cells. Loss of MST4 
resulted in decreased YAP phosphorylation in response to actin disruption, and 
also increased total abundance of TAZ, but interestingly did not affect levels of 
phosphorylated LATS. Overexpression of wild-type MST4 activated Hippo 
signaling and promoted TAZ degradation, which correlated to the effects MST4 
		 vii 
had on levels of HIF1α. MST4 may be playing a previously unappreciated role in 
regulation of Hippo tumor suppressor signaling via a LATS1/2-independent 
pathway.
		 viii 
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INTRODUCTION 
Introduction to the Hippo Pathway  
   
The Hippo pathway was initially discovered in Drosophila melanogaster as 
a key regulator of organ size, which is largely conserved in mammalian cells 
(Harvey, K and Tapon, N, 2007).  Unsurprisingly, dysregulation of the Hippo 
pathway has been implicated in numerous neoplastic disorders, including ovarian, 
liver, lung, pancreas and esophagus cancers (Harvey, K et al., 2013).    
The Hippo pathway serves to regulate oncoproteins YAP and TAZ (Yki in 
D. melanogaster). YAP/TAZ are transcriptional co-activators, which promote the 
Figure 1: Simplified schemata of the Hippo pathway.   
When the Hippo pathway is turned "On" (Right) Upstream signals such as 
TAO Kinases and MAP4Ks direct Phosphorylation of LATS1/2 which will 
then phosphorylate YAP/TAZ to sequester them out of the nucleus and 
induce their degradation.  When the Hippo pathway is “Off” YAP/TAZ remain 
unphosphorylated in the nucleus to transcribe pro-growth genes and the cell 
enters a pro-growth state. 
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expression of genes that are critical for cell growth and survival. In Drosophila, 
activation of the Hippo pathway results in Hpo associating with the scaffolding 
protein Sav, which stabilizes Hpo, promotes its interaction with the Wts kinase, and 
ultimately results in Wts phosphorylation (Pantalacci et al., 2003; Wu S, et al., 
2003; Udan R et al., 2003; Harvey K, et al., 2003).   Phosphorylated Wts will then 
associate with protein Mats to phosphorylate Yki (Wei X, et al., 2007).  
Phosphorylated Yki is retained in the cytoplasm via binding to 14-3-3 proteins and 
is degraded via an ubiquitin-proteasome-dependent pathway (Oh H and Irvine KD, 
2008; Tumaneng K, et al., 2012, Zhao B, et al., 2007, and Zhao B, et al., 2010).   
Core components of the Hippo cassette are also largely conserved from 
Drosophila to mammalian cells.  In mammalian cells, upon activation of Hippo 
signaling, MST1/2 bind to SAV1 via the C-terminal domains of SAV1; this 
interaction promotes MST1/2 phosphorylation of LATS1/2 at the hydrophobic motif 
(T1079 in LATS1 and T1041 in LATS2) (Callus BA, et al., 2006; Meng Z, et al., 
2016). Following this event, MOB1A/B are recruited to LATS1/2, which results in 
a conformation shift in LATS that facilitates auto- and trans-phosphorylation of 
LATS1/2 at their activation loops (S909 in LATS1 and S872 in LATS2) (Hergovich 
A and Hemmings BA, 2009; Visser S and Yang X, 2010; Hergovich A, 2013;). This 
tandem phosphorylation sequence allows for full LATS activation, and results in 
the phosphorylation of YAP and TAZ.  Phosphorylation of YAP/TAZ at LATS 
consensus sites at several serine residues promotes binding of phosphorylated 
YAP/TAZ by 14-3-3 proteins, which cytoplasmically sequester YAP/TAZ (Freeman 
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AK and Morrison DK, 2011; Moroishi T, et al., 2015; Shanzer M, et al., 2017). Upon 
sequestration, then, YAP/TAZ become phosphorylated at phosphodegron motifs 
by Casein Kinase 1 (CK1), which allows the recruitment of SCF-β-TRCP E3 
ubiquitin ligase to YAP and TAZ. This ultimately results in the degradation of 
YAP/TAZ via the ubiquitin-proteasome pathway (Zhao B, et al., 2010).  
However, MST1/2 are not the only kinases that have been shown to 
promote Hippo signaling. TAO (Thousand-and-One) Kinases 1-3 (TAOK1/2/3) 
were recently identified as regulators of MST1/2 and LATS1/2 (Plouffe S, et al., 
2016).  Interestingly, TAOKs have also been shown to be activated in response to 
DNA damage (Raman M, et al., 2007), which may lead to Hippo pathway activation 
in the presence of DNA damage to prevent further cell cycle progression.  Another 
class of kinases that were recently shown to turn on Hippo signaling are the 
MAP4K (Mitogen-activated protein kinase kinase kinase kinase) family of kinases, 
which directly phosphorylate LATS1/2 (Meng Z, et al., 2015, Zheng et al. 2015).  
Hippo signaling is also regulated via G-protein-coupled receptors (GPCRs). 
GPCRs can either stimulate or inhibit LATS1/2 activity depending on the 
abundance and type of ligands available, and therefore modulate levels of 
YAP/TAZ in the nucleus in response to extracellular inputs.  Indeed, it has been 
observed that while epinephrine stimulates LATS1/2 activity, LPA has been shown 
to do the inverse via the same class of GPCRs (Yu F, et al., 2012).  Signaling at 
the cell membrane have also been shown to regulate Hippo activation, as NF2, a 
membrane-bound protein, facilitates MST1/2-dependent activation of LATS 
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kinases via plasma-membrane recruitment of these proteins (Hergovich A, et al., 
2006, Pan D, 2010; Reginensi A, et al., 2016;).  
Given that the Hippo pathway responds to such a diversity of inputs, it is no 
surprise that Hippo signaling also responds to mechanotransductive stimuli. 
Crumbs, α-catenins, β-catenins, and angiomotins are all examples of proteins 
involved with mechanotransduction that are also modulators of YAP/TAZ activity.  
In particular, angiomotins and angiomotin-like proteins have been shown to directly 
regulate YAP in response to cellular actin polymerization; during conditions of 
regular cytoskeletal tension, angiomotins remain bound to F-actin, and therefore 
allow YAP to translocate to the nucleus. However, upon actin depolymerization, 
angiomotins become dissociated from F-actin, bind to YAP, and sequester YAP at 
the membrane (Ono S, 2007; Mana-Capelli S, et al., 2014; Low BC, et al., 2014; 
Piccolo S et al., 2014). Research has also shown that cadherins, which modulate 
cell adhesion and junction formation, also regulate Hippo signaling.  E-cadherin 
expression, which occurs in the context of facilitating adhesion at the cell surface, 
has been shown to enhance YAP cytoplasmic localization (Kim NG, et al., 2011; 
Kruse K and Komarova YA, 2015).  
 Yet another activator of Hippo signaling is contact inhibition. Contact 
inhibition is a key property exhibited in non-transformed cells in which they halt 
proliferation upon reaching confluence. Under conditions of functional Hippo 
pathway inactivation, such as with overexpression of YAP, contact inhibition is lost 
(Zhao B, et al., 2007). Underlying mechanisms for how contact inhibition activates 
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Hippo signaling still remain to be fully characterized. Recently, it was shown that 
under cytoskeletal tension, F-actin stress fibers bind to vinculin, which 
subsequently recruits TRIP6 to adherens junctions. At the adherens junctions, 
TRIP6 then competes for, and binds to LATS to prevent MOB1 recruitment, 
thereby inhibiting LATS activation and promoting YAP/TAZ stabilization. When 
cells are grown to confluence, however, TRIP6 dissociates from LATS and allows 
appropriate binding and activation of LATS by MOB1 proteins, thereby resulting in 
YAP/TAZ inhibition, and a cessation of cellular proliferation (Wada KI, et al., 2011; 
Kruse K and Komarova YA, 2015; Dutta S, et al., 2018). 
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Mammalian Ste20 Kinases 
 
Figure 2: Evolutionary Tree Diagram of Mammalian Ste20 Kinases 
Adapted from Meng et al., 2015  
 
As might be expected, evolutionary divergence and diversification has 
resulted in the presence of multiple kinases that are structurally related to MST1 
and 2 in mammalian cells. Of these, MST3, MST4, and YSK1/SOK1/STK25 are 
particularly of interest, mainly due to largely conserved structural similarities that 
exist between MST1/2 and MST3/4/YSK1. MST1/2 belong to the GCK-II subfamily 
within the MST superfamily, while MST3/4/YSK1 belong to the GCK-III subfamily. 
(Galan J and Avruch J, 2016, Zhang M, et al., 2013). The main difference between 
the GCK-II and –III subfamilies is the presence of protein-protein interacting 
SARAH (Salvador-RASSF-Hippo) domains in the C-terminal regions of MST1/2, 
which are absent in MST3/4/YSK1 (Fallahi E, et al., 2016).  MST1/2 depend on 
their SARAH domains to drive their interactions with Sav1 and NF2, as well as with 
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RASSF (Ras association domain family) (Donninger H, et al., 2007; Donninger H, 
et al., 2016; Bitra A, et al., 2017). It is thought that the SARAH domain performs 
an essential role in facilitating auto-phosphorylation-dependent activation of 
MST1/2, and subsequent phosphorylation of LATS1/2 (Hergovich, A., 2012). 
 
MST3, MST4 and YSK1/SOK1/STK25 lack a SARAH domain on their C-
termini and instead possess a highly conserved region with coiled-coil and low-
complexity domains, whose functions remain unclear (Ceccarelli DF, et al., 2011). 
Interestingly, GCK-III subfamily kinases also belong to a group of proteins called 
the STRIPAK complex, which has been implicated in regulation of Hippo signaling 
in large-scale bioinformatic and proteomic studies (Kean MJ, et al., 2011, Chen C, 
Figure 3: Functional Domains of GCKII and GCKIII Subfamily 
Kinases 
(Taken from Pombo CM, et al., 2007).  Used to show the structural 
differences between the MST Kinases.  (Note SOK1 = MST5 = 
STK25), just as in Figure 2.  Note the absence of the SARAH Domain 
that characterizes MST1/2.  NLS = Nuclear Localization Signal, NES = 
Nuclear Export Sequence.   
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et al., 2014).  The STRIPAK complex modulates a variety of signaling cascades, 
regulating numerous functions and processes including cell cycle control, 
apoptosis, cell polarity, and cell migration (Hwang J and Pallas DC, 2014, Madsen 
CD et al. 2015).  Interestingly, a member of the STRIPAK complex, PP2A, has 
been shown to inactivate Hippo signaling by dephosphorylating and thereby 
turning off MST1/2 activity (Zheng Y, et al., 2017; Bae JS, et al., 2017). It is 
tempting to hypothesize, then, that given PP2A is a phosphatase that turns off 
Hippo signaling, that MST3/4/YSK1 might play an opposing role to PP2A and turn 
on Hippo signaling.    
Interestingly, there is some evidence to suggest that this might be the case. 
MST3 was discovered to participate in regulation of the NDR (Nuclear Dbf-2-
Related) protein kinases that help control the cell cycle.  MST3 mediated 
phosphorylation of NDR protein kinases activates them to phosphorylate their 
target substrates and is a  critical step in permitting G1àS phase transition (Stegert 
M, et al., 2005; Cornils H, et al., 2011). This is particularly interesting, as LATS1/2 
belong to the same family of kinases as NDR1/2, suggesting that there might exist 
a conserved GCK-III-NDR/LATS kinase regulatory axis in human cells. However, 
little work has been done to further elucidate the roles that MST4 or YSK1 might 
play in regulation of Hippo signaling.  
MST4 is a ubiquitously expressed kinase that has been found to have the 
highest expression levels in the placenta, blood and thymus (Lin, J et al., 2001).  
Its functions remain poorly characterized, but it is known to localize to the Golgi 
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apparatus via interactions with GM130 (Preisinger C, et al., 2004).  Some known 
functions for MST4 involve its roles in regulation of cell polarity. MST4 helps to 
define apico-basal polarity in the digestive tract, particularly downstream of LKB1, 
wherein MST4 promotes brush border formation via phosphorylation of ezrin 
(Fehon et al. 2010).  Furthermore, LKB1-MST4 signaling has also been shown to 
be essential for the proper localization of H+-ATPase pumps at the apical border 
of gastric parietal cells (Jiang H, et al., 2015). Interestingly, this LKB1-MST4 axis 
appears to be critical wherever appropriate polarization of cells is necessary, as 
neuronal polarization secondary to Golgi reorientation appears to depend at least 
in part on MST4 (Huang W, et al., 2014).  Given then, that both polarity signaling 
and LKB1 signaling have been implicated in regulation of Hippo pathway 
components, it is possible that MST4 might play similar roles in regulating Hippo 
signaling, either in conjunction with, or downstream of, such identified upstream 
components.  
Specific Aim and Rationale  
 MST4 is structurally highly similar to MST1/2, mammalian orthologs of 
Drosophila Hpo kinase. Furthermore, MST4 is postulated to play an opposing role 
in PP2A in the context of STRIPAK signaling; PP2A has since been identified as 
a negative regulator of Hippo signaling. We therefore sought to characterize the 
role that MST4 plays in regulation of Hippo signaling in response to well-
characterized stimuli, such as cytoskeletal disruption and contact inhibition, as well 
as in the context of cellular polarization in epithelial cell lines.
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MATERIALS AND METHODS 
Cell Lines and Culture 
• BJ Fibroblasts were obtained from ATCC and were cultured in DMEM/high 
glucose +10% FBS, and 1% Penicillin/Streptomycin (Invitrogen) at 37o 
Celsius in 5% humidified CO2.   
• HK-2 kidney proximal tubule cells were a generous gift from Dr. Herbert 
Cohen (Boston University Medical Campus) and were cultured in 
DMEM/high glucose +10% FBS and 1% Penicillin/Streptomycin at 37o 
Celsius in 5% humidified CO2 
• IMR-90 fibroblasts were obtained from ATCC and were cultured in 
DMEM/high glucose +10% FBS, and 1% Penicillin/Streptomycin (Invitrogen) 
at 37o Celsius in 5% humidified CO2.   
• MCF10A were acquired from ATCC and were cultured in DME/F12 +10% 
Horse Serum, 1mg/mL hydrocortisone, 100ng/mL cholera toxin, 10µg/mL 
insulin and 1% Penicillin/Streptomycin at 37o Celsius in 5% humidified CO2 
(media recipe adapted from Brugge Lab, Harvard Medical School) 
• RPE-1 were cultured in DME/F12 +10% FBS and 1% 
Penicillin/Streptomycin at 37o Celsius in 5% humidified CO2 
Lipofectamine® Transfections  
 Cells were treated at 50-70% confluence for Lipofectamine® RNAiMAX 
(ThermoFisher) treatment.  First, 100µL of Opti-MEM® (ThermoFisher) and 5.5µL 
Lipofectamine® RNAiMAX were permitted to incubate at room temperature for a 
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period of 5 minutes.  Afterwards, this 105.5µL mixture was added to a mixture of 
100µL O-MEM plus 110 picomoles of siRNA.  This mixture was then incubated at 
room temperature for a period of 15 minutes.   
 During the 15-minute incubation period.  Cells were washed twice with 1X 
PBS (ThermoFisher) and then treated with 2mL of penicillin/streptomycin free 
media (total siRNA concentration was therefore 0.05 µM.  The ~200µL transfection 
mixture was then added to the cells and they were left in a 37oC/5% CO2 incubator 
for a period of 4 hours.  After which transfection media was changed to fresh 
media.  Cells were then harvested after a period of 48 hours.   
 For transfections of 12-well plates, as required for immunofluorescent 
experiments, all amounts were halved.   
Generation of MST4 Overexpressing Cells 
In order to generate MST4 overexpressing BJ Fibroblast and RPE-1 cells 
for analysis, we utilized the pWZL retroviral vector.  MST4 was cloned via 
restriction enzyme digest with BamHI and XhoI (New England Biolabs) from the 
pLDNT7_NFLAG vector (DNASU).  MST4 was incorporated into the pWZL-Myc 
(Addgene) vector via digestion with restriction enzymes BamHI and XhoI.  Gel 
purification was then utilized to obtain the MST4 insert.  Ligation was performed 
using a T4 DNA ligase and the ligation product was transformed into DH5α 
chemically competent E. coli. Clones were screened via restriction enzyme digest 
and correct inserts were verified by DNA sequencing (Genewiz).    
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The viral infection protocol was performed as previously described (Ganem N, et 
al., 2014).  RPE-1 and BJ Fibroblasts were infected for 12-16 hours with viral 
supernatant in the presence of 10µg/mL of Polybrene (Santa Cruz Biotechnology) 
overnight.  Following infection, blasticidin was used to select virally transduced 
cells over a period of 2 weeks at a concentration of 5µg/mL for BJ Fibroblasts and 
10µg/mL for RPE-1 cells. 
Protein Collection 
First, cells of interest were washed twice with ice-cold Phosphate Buffered 
Saline (PBS) (Life Technologies) and then the cells were lysed with a Laemli Lysis 
Buffer solution (2% SDS, 10% Glycerol, 60mM Tris-HCl in Milli-Q deionized water) 
which was supplemented with 1X HALT protease and phosphatase inhibitor 
(ThermoFisher). 
Cells were immediately scraped off the plate and collected and then sonicated 
twice (Model CL-18, Fisher Scientific) for a period of 20 seconds at 20kHz.  After 
sonication, samples were treated with a 4X reducing buffer (Boston Bioproducts) 
such that the total solution was made to be 1X.  Samples were vortexed and then 
pulse-centrifuged.  Finally, the protein samples were boiled at 95o Celsius for a 
period of 5 minutes.   
Making Polyacrylamide Gels for SDS-PAGE 
 In order to make the resolving layer of the gel, a 1.5 mL of 40% Acrylamide, 
1.88 mL of Resolving buffer solution (0.5 M Tris Base, 0.4% SDS, pH 6.8), 4.1 mL 
of Milli-Q deionized water, 38 µL of TEMED and µL of 10% APS were poured into 
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a gel cast (Bio-Rad), and allowed to polymerize for a period of at least 20 minutes.  
After polymerization of the resolving layer occurred, 370 µL of 40% acrylamide, 
0.94 mL stacking buffer (1.5 M Tris base, pH 8.8, Fisher Bioreagents), 2.42 mL 
Milli-Q deionized water, µL APS and 11 µL TEMED were then poured to create the 
stacking layer and a 15-well comb was used in order to create the wells.   
SDS-PAGE 
 Protein samples were loaded into 8% polyacrylamide gels and the samples 
were separated for a period of 15 minutes at 130V after which the voltage was 
increased to 230V for an additional 26 minutes, or until the dye front resolved from 
the gel completely (Bio-Rad).  A standard Towbin running buffer composition was 
utilized (0.025M Tris, 0.2M Glycine, and 0.05% SDS).  
Protein Transfer 
 Protein extracts ran on polyacrylamide gels were then transferred to 
Polyvinylidene Fluoride (PVDF) Membranes (Bio-Rad) using a wet-tank transfer 
method. A modified Towbin Transfer buffer recipe was utilized (0.027M Tris, 0.025 
M Glycine, and 10% v/v methanol). The transfer buffer was used ice-cold and kept 
cold via the use of an ice pack and surrounding the outside of the transfer 
apparatus with ice.  Protein transfer was performed for 60 minutes at 90V.   
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Blocking and Antibody Binding 
Table 1: Antibodies Used for Experiments 
Antibody Antibody 
Raised In: 
Identification Concentration 
P-LATS1-T1079 Rabbit Cell Signaling – D57D3 1:1000 
LATS1 Rabbit Cell Signaling – C66B5 1:500 
P-YAP-S127 Rabbit Cell Signaling – D9W2I 1:1000 
YAP Rabbit Cell Signaling – D8H1X 1:1000 
TAZ Rabbit Cell Signaling – V386 1:1000 
MST4 Rabbit Abcam – ab52491 1:1000 
HIF1α Rabbit Cell Signaling – D2U3T 1:1000 
GAPDH Rabbit Cell Signaling – 14C10 1:5000 
α-TUBULIN Mouse Millipore – DM1A 1:10000 
Anti-Rabbit Goat Cell Signaling – 7074S 1:5000 
Anti-Mouse Goat Cell Signaling – 7076S 1:5000 
 
 Following transfer, the PVDF membrane was blocked in 5% non-fat dried 
milk-TBS Tween solution (0.02 M Tris, 0.15 M NaCl, 0.2% Tween-20, pH 7.6) for 
a period of 1 hour at room temperature.  After blocking, the membrane was 
incubated overnight with the indicated primary antibodies (Table 1) at 4o C with 
end-over-end rocking.    
 Following overnight incubation with the primary antibody, the membrane 
was washed vigorously 3 times with TBS-Tween for 10 minutes per wash.  After 
the washes, an appropriate horseradish peroxidase conjugated secondary 
antibody (Table 1) was diluted 1:5000 in a 1% Milk-TBS-Tween solution and gently 
rocked for 1h.  After incubation with the secondary antibody was completed, the 
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PVDF membrane was washed vigorously 3 times with TBS-Tween for 10 minutes 
per wash. 
 Following the wash protocol, a chemiluminescent reagent (Clarity Max® 
and Clarity® Western Substrate Bio-Rad) was applied to the PVDF membrane for 
a period of 5 minutes, after which visualization of the reaction was performed by 
autoradiography (ChemiDoc Imager, Bio-Rad) and quantified with Image Lab 
software (Bio-Rad) according to manufacturer instructions. 
Immunofluorescence Seeding 
All immunofluorescence experiments involved cells seeded in 12 well plates 
(Fisher Scientific) with glass coverslips (Electron Microscopy Sciences) overnight 
and then were transfected with siRNAs at 50% confluence as described above. 
Immunofluorescent Histocytochemistry 
 In order to fix cells onto glass coverslips, glass coverslips were first washed 
with PBS for 1 min and then cells were fixed with 4% Paraformaldehyde/PBS 
(Electron Microscopy Sciences) at room temperature for 20 minutes.  Cells were 
then extracted in a 0.5% Triton/PBS solution for 5 minutes and then blocked in a 
5% TBS/BSA solution for 30 minutes.  After blocking, cells were incubated in the 
following primary antibody solution (all diluted in 5% TBS/BSA for 1 hour, primary 
antibody Mouse-YAP63.7 (Santa Cruz Biotechnology, concentration 1:100).   
After primary antibody treatment, a 5-minute wash in 5% TBS/BSA was 
performed and then the following solutions diluted in 5% TBS/BSA were applied 
for 30 minutes: 1:100 Mouse-Alexa Fluor® 488 secondary antibody antibody (Life 
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Technologies), 1:250 rhodamine phalloidin for actin visualization (Thermo Fisher 
Scientific), 1:2500 Hoescht stain for DNA.  After 30 minutes cover slips were 
mounted on glass slides (FisherFinest®) with a prolong antifade solution 
(Molecular Probes) 
Imaging 
 All images were obtained using a Nikon Eclipse Ti inverted epifluorescence 
microscope (Nikon).  Image analysis was performed using NIS-Elements Software 
(Nikon). In order to reduce bias, image capture and analysis were performed in a 
blinded fashion.   
Statistical Analysis 
Statistical analysis was performed with GraphPad Prism version 7.02.  Unless 
indicated otherwise, all experiments were replicated at least 3 times and p < 0.05 
was used as the threshold for statistical significance. For dot-whisker plots, a 
Mann-Whitney test was used to determine significance.  For quantitation of 
Western Blots, paired t-tests were used to determine statistical significance.  
Finally, for the deconvolved siRNA experiment in which linear regression was 
performed, a Pearson linear regression was performed in order to determine the 
significance of the R2 for the graph.    
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RESULTS AND DISCUSSION 
MST4 knockdown in polarized cell lines does not significantly alter 
YAP phosphorylation Levels 
 
To assess the effects of MST4 knockdown in polarized epithelial cells, we 
chose to use two well-validated cell lines, MCF10A, and HK2. MCF10A cells are 
non-transformed mammary gland epithelial cells that exhibit canonical epithelial 
characteristics – among those are lack of anchorage independent growth, 
cobblestone morphology, and formation of dome-structures when grown in 
confluence (Soule H, et al., 1990). HK2 cells are immortalized from the proximal 
tubule of the kidney and like MCF10A cells are well-defined epithelial cells that 
lack anchorage independent growth and form dome-structures when grown to 
confluence (Ryan M, et al., 1994).   
 To activate Hippo signaling and allow for detection of changes in YAP 
phosphorylation status, we treated our cells with 10 µM dihydrocytochalasin B 
(DCB), which is an inhibitor of actin polymerization. Actin cytoskeletal tension is a 
critical regulator of Hippo signaling, and disruption of actin architecture with loss of 
cytoskeletal tension promotes YAP phosphorylation in a LATS-dependent fashion 
(Meng Z, et al., 2015, Zheng Y, et al., 2015, and Dupont S, et al., 2011). 
Interestingly, we found that loss of MST4 did not have any significant effects of 
YAP phosphorylation in MCF10A (Figure 4), though, as expected, knockdown of 
LATS1/2 decreased YAP phosphorylation by approximately 75%. However, we did 
note a trend towards decreased YAP phosphorylation after MST4 knockdown, 
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suggesting that MST4 might play a role in regulation of Hippo signaling. We also 
found similar phenotypes in HK2 cells, wherein knockdown of MST4 did not 
produce statistically significant decreases in YAP phosphorylation, though loss of 
LATS1/2 did again decrease YAP phosphorylation robustly (Figure 5). One 
possible reason for this phenotype in which we see trends towards decreased YAP 
that are statistically insignificant may be due in part to the lack of statistical power 
intrinsic to quantitative immunoblotting protocols, and that additional replicates 
may be necessary to detect statistical differences between our control and MST4 
groups.   
Figure 4: MST4 knockdown in MCF10A does not affect YAP 
phosphorylation. 
(Left) Western Blot of YAP and LATS phosphorylation following 
knockdown of MST4 or LATS1/2 in MCF10A cells.  GAPDH was used as 
a loading control.  (Right) Quantitation of P-YAPS127/Total YAP Ratios (N = 
3); N.S. = Not Significant; * indicates p<0.05.  
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In addition to quantitative immunoblotting protocols, we turned to 
immunofluorescence in order to assess nuclear and cytoplasmic localization of 
YAP in HK2 cells that were transfected with siRNAs targeted towards MST4 
(Figure 6).  Relative to control, we found that knockdown of MST4 did increase 
levels of nuclear YAP localization in HK2 cells, but that the change between 
siMST4 and our control cells were very subtle, suggesting that the role that MST4 
plays in epithelial cells with respect to regulation of Hippo signaling may be 
moderate at best.    
 
Figure 5: MST4 knockdown in HK2 does not affect YAP phosphorylation. 
(Left) Western Blot Showing effects of siRNA mediated knockdown of MST4 on 
levels of P-LATS1T1079, LATS1, P-YAPS127, and YAP in HK2 Cells.  GAPDH was 
used as a loading control.  (Right)  Quantitation of P-YAPS127/YAP Ratios, (N=3); 
N.S. = Not significant; * indicates p<0.05  
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Figure 6: Immunofluorescent localization of YAP under 
conditions of MST4 knockout in HK2 cells  
(Top) HK2 cells stained for YAP (Green) 48 hours post-
transfection with siC, siMST4 and siLATS1/2. Actin (Red) and 
DNA (White) were also visualized.  (Bottom) Dot-Whisker plot 
of immunofluorescent data with the Y axis representing 
nuclear/cytosolic YAP ratio.  N = 225 per condition; *** 
indicates p<0.01; **** indicates p<0.0001.  siLATS1/2 was 
used as a positive control. 
	21 
This data supported our observations made with immunoblotting in both 
MCF10A and HK2 that while there is a trend towards a decrease in YAP 
phosphorylation upon MST4 knockdown, the biologic significance of this effect 
may be minor at best. Indeed, quantitation of YAP localization in HK2 cells 
suggests that though a trend exists, depletion of MST4 in polarized epithelial cells 
appears to be insufficient to turn off Hippo signaling. One possible explanation is 
that loss of MST4 may be insufficient to modulate Hippo signaling in these 
polarized cell lines, as polarization is known to promote the formation of protein 
complexes at the cell membrane which activates Hippo signaling. Another 
possibility is that other Hippo-activating proteins become up-regulated to 
compensate for MST4 loss in polarized epithelia; some possible candidates 
include Crumbs3 (Szymaniak AD, et al., 2015), Par3 (Zhang P, et al., 2016), and 
Scribble (Zhao B, et al., 2010), which are known to regulate Hippo signaling in the 
context of polarized epithelia.  
 
MST4 knockdown significantly alters YAP phosphorylation and 
localization in non-polarized cells. 
 
We next sought to examine the role of MST4 in the context of non-polarized 
cell lines. We hypothesized that the effect of MST4 might be accentuated in the 
absence of functional polarity complexes that typically activate Hippo signaling, as 
there would be fewer available mechanisms to compensate for MST4 loss, should 
MST4 be a positive regulator of Hippo signaling. To this end, we utilized hTERT 
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RPE-1 cells, which, though from an epithelial cell of origin, do not exhibit polarized 
qualities that are associated with cell polarity. For example, hTERT RPE-1 lack 
Crb1, one of the three Crumbs homologs (Paniagua A, et al., 2015). Furthermore, 
hTERT RPE-1 lacks expression of E-Cadherin, but instead expresses high levels 
of N-Cadherin, suggesting that hTERT RPE-1 may exist in an in-between state 
between epithelial and mesenchymal phenotypes (Burke J and Hong J, 2006; Perl 
A, et al., 1998).  
In order to assess the role that MST4 plays in regulating Hippo signaling in 
RPE-1 cells, we used the same protocol as in MCF10A and HK2 cells. 
Interestingly, we observed that YAP phosphorylation was significantly reduced 
under both DMSO and DCB treatment conditions following MST4 knockdown in 
Figure 7: MST4 knockdown in RPE-1 cells results in significant 
decrease of phosphorylated-YAP/YAP 
(Left) Western Blot showing effects of siRNA mediated knockdown 
of MST4 on levels of P-LATS1T1079, LATS1, P-YAPS127, and YAP in 
RPE-1 Cells.  GAPDH was used as a loading control and siLATS1/2 
was used as a positive control.  (Right) Quantitation of Western Blot.  
N = 3; *  indicates that p< 0.05; ** indicates that p < 0.01; *** 
indicates that p < 0.001 
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RPE-1 cells (Figure 7).  This was particularly surprising to us, as we were able to 
detect a decrease in YAP phosphorylation in the absence of a stimulating influence 
such as treatment with DCB. Moreover, given that the relative ratio of YAP 
phosphorylation decreases seen remained consistent between our DMSO treated 
and DCB treated conditions, this suggested to us that MST4 may globally turn 
down Hippo signaling in RPE-1 cells. However, we also noted that levels of LATS 
phosphorylation did not decrease, suggesting that MST4 might act independent of 
LATS1/2 to regulate YAP phosphorylation.  
 
 
Next, we wished to confirm whether this phenotype was conserved across 
other non-polarized cell lines. We decided to use two fibroblastic cell lines, BJ 
fibroblasts and IMR90 fibroblasts.  MST4 was depleted in BJ fibroblasts as before, 
and Hippo pathway activation was induced via treatment with DCB. We also added 
Figure 8: MST4 knockdown in BJ Fibroblasts results in decrease 
of phosphorylated-YAP/YAP 
BJ Fibroblasts (N = 1) treated with DCB and Lat. A were subjected to 
siRNA knockdown of MST4. P-YAPS127/YAP ratios are presented 
below the YAP immunoblot.  
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an additional treatment condition with Latrunculin A to ensure that any phenotypes 
that we observed would not be unique to DCB treatments. As expected, we found 
that loss of MST4 decreased YAP phosphorylation by approximately 30-40% 
irrespective of the treatment conditions (Figure 8). However, we noted once again 
that levels of phosphorylated LATS did not decrease, further suggesting that MST4 
may impinge on YAP phosphorylation via a LATS1/2-independent pathway. 
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We also performed immunofluorescent subcellular localization of YAP to 
ensure that our observations were not limited to immunoblotting. Subcellular 
Figure 9: siRNA knockdown of MST4 in IMR90 fibroblasts significantly 
increases nuclear YAP localization  
 
(Top) YAP (Green) staining in IMR90 fibroblasts following knockdown of MST4. 
Actin (Red) and DNA (White) are also shown. Data courtesy of Tenny Mudianto.   
(Bottom Left) Quantitation of immunofluorescence experiment; Y-axis represents 
normalized nuclear:cytoplasmic YAP ratios (N=225). **** indicates 
 p < 0.0001.  (Bottom right) Cells were additionally scored as having cytoplasmic, 
equal or nuclear levels of YAP. Proportions of cells in each category are 
presented graphically (N=225).  
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localization of YAP/TAZ was performed following MST4 knockdown as before in 
IMR90 fibroblasts, which are primary lung fibroblasts that do not exhibit apico-
basal polarity (Nichols WW, et al., 1977).  Consistent with our immunoblotting 
results, we found that siRNA mediated knockdown of MST4 in IMR90s resulted in 
a significant (P<0.0001) increase in levels of nuclear YAP/TAZ localization (Figure 
9). Indeed, we also noted that not only did levels of nuclear YAP increase, but 
there was also a greater fraction of cells with nuclear YAP, suggesting that loss of 
MST4 inactivates Hippo signaling to promote YAP/TAZ activity in non-polarized 
cell lines.  
 
MST4 levels negatively correlate to TAZ levels in non-polarized cell 
lines 
At this point, we wished to assess the effects of MST4 on TAZ, as YAP and 
TAZ are functional paralogs in the Hippo pathway that are regulated via the same 
signaling cascade.  
In order to assess effects of MST4 knockdown on TAZ levels, we used 
siRNA to knockdown MST4 in MCF10A and RPE-1 cells as before and performed 
quantitative immunoblotting. We used total TAZ levels as a readout in this case as 
TAZ has been shown to be rapidly degraded upon activation of Hippo signaling; 
conversely, turning off Hippo signaling has been shown to do the opposite, 
resulting in stabilized levels of total TAZ protein (Finch-Edmonson ML et al. 2015). 
Indeed, it has been reported that due to the presence of two phosphodegron motifs 
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in TAZ as compared to one motif in YAP, TAZ tends to be less stable than YAP 
and is degraded faster than YAP under similar conditions of Hippo pathway 
activation (Liu CY, et al., 2010 and Moroishi T, et al., 2015). 
 
We found that knockdown of MST4 resulted in statistically significant increases in 
total TAZ levels in RPE-1 cells, but not in MCF10A cells, once again validating our 
observations that the effects of MST4 appear to be specific to non-polarized cell 
lines (Figures 10, 11).  At this point, we wished to rule out potential off-target effects 
from utilizing a pool of siRNA oligonucleotides directed against MST4, and thus 
utilized a series of eleven deconvolved single siRNA sequences directed against 
MST4, obtained from two different companies, in which six targeted the ORF and 
four targeted the 3’ UTR. This diversity of targeted regions and sequences would 
allow us to conclusively verify whether our phenotype of increased TAZ expression 
Figure 10: MST4 knockdown in RPE-1 cells increases total TAZ levels. 
 
(Left) Western Blot showing TAZ levels in RPE-1 cells.  GAPDH is used a 
loading control.  (Right) Quantitation of TAZ levels.  N = 3; * indicates p 
<0.05 
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was due to MST4 knockdown, or whether it was due to other RNAi-mediated 
effects. 
 
As expected, we found that not only did all ten of the siRNA directed against 
MST4 increase TAZ levels, we also saw that there existed a positive linear 
correlation between the levels of TAZ and efficiency of MST4 knockdown (Pearson 
R2 = 0.7278, p=0.0008) (Figure 12). This gave us confidence that off target effects 
were not contributing to the corresponding increase in TAZ, and that knockdown 
of MST4 was indeed driving our phenotype of increased TAZ protein levels.  
In order to further validate the strength of our hypothesis, we next wished 
to assess whether overexpression of MST4 could turn on Hippo signaling to reduce 
Figure 11: MST4 knockdown in MCF10A cells does not alter TAZ 
levels at all. 
 
(Left) Western Blot showing effects of MST4 knockdown of TAZ levels in 
MCF10A cells.  GAPDH is used a loading control and LATS1/2 
represents a positive control (Right Quantitation of TAZ levels.  N = 3; 
N.S. = Not significant; * indicates p < 0.05  
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levels of total TAZ protein. To do this, we virally transduced RPE-1 and BJ 
fibroblast cells with a retroviral vector encoding a FLAG-tagged version of wild-
type MST4. As control, we infected RPE-1 and BJ fibroblast cells with a retrovirus 
encoding GFP, driven by the same expression vector as that for MST4. Following 
induction with retrovirus, we found that overexpression of wild-type MST4 
significantly reduced levels of TAZ in both the BJ fibroblast and RPE-1 cells 
compared to control cells, suggesting that overexpression of MST4 activates Hippo 
signaling to reduce levels of total TAZ protein (Figures 13). 
 
Overall, our data indicates that MST4 plays a previously unappreciated role 
in modulating TAZ stability in non-polarized cell lines. Interestingly, we noted that 
the effects of MST4 loss and overexpression appeared to be much more robust 
than its effects for YAP. This may very well be explained by the fact that TAZ is 
Figure 12: Deconvolved siRNA knockdown of MST4 results in consistent 
increase in TAZ expression 
(Left) Western Blot for MST4 Deconvolved siRNA experiment.  Alpha tubulin is 
used as a loading control.  OTP = ON-TARGETplus Dharmacon siRNA.  (Right) 
Linear regression analysis performed.  R2 = Pearson’s Test statistic.     
	30 
less stable than YAP, such that even subtle changes in Hippo pathway activation 
may result in significant changes in total levels of TAZ. Another possible 
explanation is that MST4 regulates TAZ via a separate, yet parallel axis to the 
standard Hippo signaling pathway, thus resulting in an accentuation of TAZ protein 
level changes upon modulation of MST4 in these cells.   
Figure 13: Expression of MST4 reduces TAZ Levels in BJ Fibroblasts 
and RPE-1 Cells 
(Left) Western Blot illustrating effects of MST4 overexpression on TAZ levels 
for RPE-1 and BJ Fibroblast cells.  GAPDH was used as a loading control.  
(Right) Quantitation of normalized TAZ levels; N = 3; * indicates p < 0.05 
	31 
 
HIF-1α levels decreased upon MST4 overexpression in RPE-1 cells 
Lastly, we wished to assess whether MST4 might impinge on other 
signaling axes to regulate TAZ protein levels. In this regard, the HIF1α signaling 
pathway is of particular interest, as MST4 has been implicated in regulating 
pituitary tumorigenesis under hypoxic conditions, though the exact mechanism 
underlying such regulation remain uncharacterized (Xiong W, et al., 2015; Xiong 
W, et al., 2016). Hypoxic conditions leading to activation of HIF1α have been 
shown to promote Hippo inactivation through expression of SIAH1, which is an 
ubiquitin ligase that promotes the degradation of LATS kinases (Xiang L, et al., 
Figure 14: MST4 overexpression results in decreased  
TAZ and HIF1α levels in RPE-1 cells 
 
(Left) Western Blot representing MST4 overexpression and its 
effects on TAZ and HIF1A levels in RPE-1 cells.  GAPDH was 
used as a loading control.  (Right) Quantitation of normalized 
HIF1α levels; N = 3; ** indicates p < 0.01 
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2014). Additionally, it has been demonstrated that hypoxia is sufficient to promote 
upregulation of TAZ in cancer cells through LATS-independent fashion (Yan L, et 
al., 2014). Indeed, it has been previously shown that HIF1α directly promotes the 
expression of TAZ and thereby promotes breast carcinogenesis (Xiang L, et al., 
2015). We therefore hypothesized that cells overexpressing MST4 might have 
lower levels of HIF1α, which would explain at least part of why MST4 modulation 
resulted in such robust changes in TAZ protein levels.  
As expected, we found RPE-1 cells stably overexpressing MST4 had 
significantly lower levels of total HIF1α relative to control cells (Figure 14). Further 
work will need to be done to validate and characterize the underlying mechanisms 
responsible for such a phenotype. 
 
Future Directions 
Taken together, MST4 appears to be a novel regulator of Hippo signaling in 
the context of non-polarized cell lines, which may impinge on both Hippo pathway 
components as well as other signaling pathways to regulate levels of active 
YAP/TAZ. Further, we found that the effects of MST4 were particularly pronounced 
on TAZ, though whether these phenotypes were due to the intrinsic instability of 
TAZ remain to be elucidated. Future experiments to validate our findings will 
include a phos-tag electrophoresis experiment to assess global levels of TAZ 
phosphorylation in cells depleted of MST4. Given the negative relationship that 
exists between phosphorylation and TAZ stability, we expect to see decreased 
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levels of TAZ phosphorylation in MST4-depleted cells. Use of a phospho-specific 
TAZ antibody to quantitatively assess levels of phosphorylated TAZ in these cells 
will also be performed.   
We also noted that MST4 was unable to significantly affect Hippo signaling 
status in polarized epithelial cells with intact polarity signaling complexes. It will be 
interesting to assess whether chemical and genetic perturbations of such polarity 
complexes sensitize these cells to MST4 depletion.  
Orthogonal approaches to further validate our findings in the context of 
siRNA-mediated knockdown will be necessary. We are currently in the process of 
generating CRISPR-Cas9 knockout cell lines that completely lack MST4 
expression, which will allow us to conclusively verify that MST4 loss definitively 
increases levels of TAZ and decreases levels of YAP phosphorylation in such cells. 
Rescue experiments in the context of siRNA-knockdown will also be performed to 
ensure that overexpression of siRNA-resistant MST4 is sufficient to restore proper 
Hippo pathway function following loss of endogenous MST4. Lastly, qRT-PCR of 
YAP/TAZ target genes in cells lacking MST4 will be performed to ensure that loss 
of MST4 activates YAP/TAZ.  
MST4 remains poorly characterized, and its downstream effectors and 
binding partners remain to be elucidated. Further work will be necessary to solidify 
the role that MST4 plays in regulating Hippo signaling, as well as in other signaling 
pathways. Our data suggests a previously unappreciated role for MST4 in 
regulating YAP/TAZ in the context of non-polarized cells, suggesting that the 
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effects of MST4 on a cell may be highly context-specific. A greater understanding 
of how MST4 integrates with other kinases and protein partners to regulate this 
essential tumor suppressor pathway will yield critical insights into how cancer cells 
functionally overcome Hippo signaling to achieve pathologic capacity.   
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